Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma

Hepato-Gastroenterology

Volumn 43, Issue 9, 1996, Pages 614-619

  Jan, Yi Yin ^a   Jeng, Long Bin ^a   Hwang, Tsann Long ^a   Wang, Chia Siu ^a   Chen, Miin Fu ^a   Chen, Tong Jong ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Factors; Hepatectomy; Mucobilia; Peripheral cholangiocarcinoma; Prognostic

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ANALYSIS; FEMALE; HUMAN; LIVER RESECTION; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0030001480     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Okuda K, Kubo Y, Okazaki N, Arishima T, Hashimoto M, Jinnouchi S, et al. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer 1977; 39 : 232-246.
2. Lygidakis NJ, Van der Heyde MN, Houthoff HJ. Surgical approaches to the management of primary biliary cholangiocarcinoma of the porta hepatis: the decision-making dilemma. Hepato-Gastroenterol 1988; 35 : 261-267.
3. Bhuiya MM, Nimura Y, Kato M, Kamiya J, Kondo S, Hayakawa N, et al. Resection of intrahepatic bile duct carcinoma with hilar bile duct and portal vein invasion - a case report. Hepato-gastroenterol 1990; 37 : 421-424.
4. Kawarada Y, Mizumoto R. Diagnosis and treatment of cholangiocarcinoma of the liver. Hepato-gastroenterol 1990; 37 : 176-181.
5. Chen MF, Jan YY, Wang CS, Jeng LB, Hwang TL. Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma. Cancer 1989; 64 : 2226-2232.
6. Ouchi K, Matsuno S, Sato T. Long term survival in carcinoma of the biliary tract. Analysis of prognostic lactors in 146 resections. Arch Surg 1989; 124 : 248-252.
7. Tompkins RK, Thomas D, Wile A, Longmire WP Jr. Prognostic factors in bile duct carcinoma; analysis of 96 cases. Ann Surg 1981; 194 : 447-457.
8. Bhuiya MMR, Nimura Y, Kamiya J, Kondo S, Nagino M, Hayakawa N. Clinicopathologic factors influencing survival of patients with bile duct carcinoma: multivariate statistical analysis. World J Surg 1993; 17 : 653-657.
9. Sato Y, VanGulik TM, Bosma A, Lygidakis NJ, Koyama K, Van der Hyder MN. Prognostic significance of tumor DNA content in carcinoma of the hepatic duct confluence. Surgery 1994; 115 : 488-494.
10. Chen MF, Jan YY, Wang CS, Hwang TL, Jeng LB, Chen SC, Chen TJ. A reappraisal of cholangiocarcinoma in patient with hepatolithiasis. Cancer 1993; 71 : 2461-2465.
11. Mizumoto R, Kawarada Y, Suzuki H. Surgical treatment of hilar carcinoma of the bile duct. Surg Gynecol Obstet 1986; 162 :153-158.
12. Tompkins RK. Treatment and prognosis in bile duct cancer. World J Surg 1988; 12 :109-110.
13. Sato Y, Tanaka J, Koyama K, Van Gulik TM, Lygidakis NJ, Van der Hyede MN. Tumor DNA content in gall bladder carcinoma. Hepatogastroenterol 1993; 40 : 375-379.
14. Alanen KA, Joensun H, Klemi PJ, Neoalainen TJ. Clinical significance of nuclear DNA content in pancreatic carcinoma. J Pathol 1990; 160 : 313-320.
15. Chen MF, Hwang TL, Tsao KL, Sun CF, Chen TJ. Flow cytometric DNA analysis of hepatocellular carcinoma: preliminary report. Surgery 1991; 109 : 455-458.
16. Oberfield RA, Rossi RL. The role of chemotherapy in the treatment of bile duct cancer. World J Surg 1988; 12: 105-108.
17. Iwasaki Y, Todoroki T, Fukao K, Ohara K, Okamura T, Nishimura A. The role of intraoperative radiation therapy in the treatment of bile duct cancer. World J Surg 1988; 12 : 91-98.